Education
About Us
Working with TipRanks
Follow Us
OrthoPediatrics Corp (KIDS)
NASDAQ:KIDS
Total Valuation
OrthoPediatrics has a market cap or net worth of $474.14M. The enterprise value is $529.72M.
Market Cap$474.14M
Enterprise Value$529.72M
Share Statistics
OrthoPediatrics has 25,073,603 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding25,073,603
Owned by Insiders33.09%
Owned by Institutions2.64%
Financial Efficiency
OrthoPediatrics’s return on equity (ROE) is -0.11 and return on invested capital (ROIC) is -6.06%.
Return on Equity (ROE)-0.11
Return on Assets (ROA)-0.08
Return on Invested Capital (ROIC)-6.06%
Return on Capital Employed (ROCE)-0.07
Revenue Per Employee364.28K
Profits Per Employee-67.30K
Employee Count562
Asset Turnover0.43
Inventory Turnover0.48
Valuation Ratios
The current PE Ratio of OrthoPediatrics is ―. OrthoPediatrics’s PEG ratio is -0.18.
PE Ratio―
PS Ratio2.61
PB Ratio1.51
Price to Fair Value1.51
Price to FCF-12.95
Price to Operating Cash Flow-16.80
PEG Ratio-0.18
Income Statement
In the last 12 months, OrthoPediatrics had revenue of 204.73M and earned -37.82M in profits. Earnings per share was -1.64.
Revenue204.73M
Gross Profit148.60M
Operating Income-29.52M
Pretax Income-41.93M
Net Income-37.82M
EBITDA-10.44M
Earnings Per Share (EPS)-1.64
Cash Flow
In the last 12 months, operating cash flow was -28.88M and capital expenditures -8.79M, giving a free cash flow of -37.67M billion.
Operating Cash Flow-28.88M
Free Cash Flow-37.67M
Free Cash Flow per Share-1.50
Dividends & Yields
OrthoPediatrics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.90
52-Week Price Change-26.65%
50-Day Moving Average21.34
200-Day Moving Average23.33
Relative Strength Index (RSI)35.91
Average Volume (3m)164.99K
Important Dates
OrthoPediatrics upcoming earnings date is Nov 5, 2025, After Close (Confirmed).
Last Earnings DateAug 5, 2025
Next Earnings DateNov 5, 2025
Ex-Dividend Date―
Financial Position
OrthoPediatrics as a current ratio of 6.98, with Debt / Equity ratio of 6.96%
Current Ratio6.98
Quick Ratio3.54
Debt to Market Cap0.14
Net Debt to EBITDA-2.81
Interest Coverage Ratio-11.26
Taxes
In the past 12 months, OrthoPediatrics has paid -4.11M in taxes.
Income Tax-4.11M
Effective Tax Rate0.10
Enterprise Valuation
OrthoPediatrics EV to EBITDA ratio is -54.04, with an EV/FCF ratio of -13.66.
EV to Sales2.76
EV to EBITDA-54.04
EV to Free Cash Flow-13.66
EV to Operating Cash Flow-20.86
Balance Sheet
OrthoPediatrics has $70.15M in cash and marketable securities with $48.11M in debt, giving a net cash position of -$22.04M billion.
Cash & Marketable Securities$70.15M
Total Debt$48.11M
Net Cash-$22.04M
Net Cash Per Share-$0.88
Tangible Book Value Per Share$8.51
Margins
Gross margin is 70.56%, with operating margin of -14.42%, and net profit margin of -18.47%.
Gross Margin70.56%
Operating Margin-14.42%
Pretax Margin-20.48%
Net Profit Margin-18.47%
EBITDA Margin-5.10%
EBIT Margin-14.42%
Analyst Forecast
The average price target for OrthoPediatrics is $32.14, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$32.14
Price Target Upside69.96% Upside
Analyst ConsensusModerate Buy
Analyst Count7
Revenue Growth Forecast26.08%
EPS Growth Forecast-63.67%